You Are Here: Deltex Medical > Investor Relations > Share Information
Share Information

Share Information

This information was last updated on 8 May 2017.


Exchanges or trading platforms on which the company has applied or agreed to have any of its securities admitted or traded.

The company’s shares are traded on AIM. There are no other exchanges or trading platforms on which the company has applied or agreed to have its shares admitted or traded. There are no restrictions on the transfer of securities.

Share Price

Number of shares in issue

The company’s issued share capital comprises 296,819,511 ordinary shares of 1p each. All of the shares are fully paid; no shares are held as treasury  shares. The percentage of shares not held in public hands is 23.74%.

Identity and percentage holdings of significant shareholders

As at 1 March 2017, the company had been notified of the following holdings of 3% or more of the voting rights of the company (as shareholder and as the direct or indirect holder of financial instruments) pursuant to transitional provision 7 of the DTR Sourcebook of the Disclosure and Transparency Rules:

  • JO Hambro Capital Management – 10.68%
  • Nigel Keen – 7.74%
  • Charles Stanley & Co. Limited – 6.61%
  • Andrew Muir – 5.34%
  • Herald Investment Management Limited – 5.23%
  • Legal and General Investment Management Limited – 5.06%
  • Barclays Wealth and Investment Management (UK) – 4.96%
  • Peter Smedvig – 4.59%
  • TD Direct Investing – 4.55%
  • Hargreaves Lansdown Asset Management – 3.71%